Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer's disease: Synthesis, in vitro characterization and brain …

D Jain, N Hasan, S Zafar, J Thakur, K Haider… - Journal of Drug Delivery …, 2023 - Elsevier
The management of Alzheimer's disease (AD) remains challenging owing to its complex
pathophysiology and blood-brain barrier (BBB) restrictions. A rationally designed …